Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tim H. Brummendorf"'
Autor:
David Baden, Sven Zukunft, Gema Hernandez, Nadine Wolgast, Sophie Steinhauser, Alexander Pohlmann, Christoph Schliemann, Jan-Henrik Mikesch, Bjorn Steffen, Tim Sauer, Maher Hanoun, Kerstin Schafer-Eckart, Stefan W. Krause, Mathias Hanel, Hermann Einsele, Edgar Jost, Tim H. Brummendorf, Sebastian Scholl, Andreas Hochhaus, Andreas Neubauer, Andreas Burchert, Martin Kaufmann, Dirk Niemann, Markus Schaich, Wolfgang Blau, Alexander Kiani, Martin Gorner, Ulrich Kaiser, Johannes Kullmer, Thomas Weber, Wolfgang E Berdel, Gerhard Ehninger, Carsten Muller-Tidow, Uwe Platzbecker, Hubert Serve, Martin Bornhauser, Christoph Rollig, Claudia D Baldus, Lars Fransecky
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
In newly diagnosed acute myeloid leukemia, immediate initiation of treatment is standard of care. However, deferral of antileukemic therapy may be indicated to assess comorbidities or pre-therapeutic risk factors. We explored the impact of time from
Externí odkaz:
https://doaj.org/article/a18a7d664edd4e4590ac8fdec959dd27
Autor:
Anna Kreutzman, Bhagwan Yadav, Tim H. Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen, Satu Mustjoki
Publikováno v:
OncoImmunology, Vol 8, Iss 9 (2019)
Changes in the immune system induced by tyrosine kinase inhibitors (TKI) have been shown to positively correlate with therapy responses in chronic myeloid leukemia (CML). However, only a few longitudinal studies exist and no randomized comparisons be
Externí odkaz:
https://doaj.org/article/d70460040d3747b5b862c7dbbae3b557
Autor:
Michael W. Deininger, Tim H Brummendorf, Jeffrey H. Lipton, Dragana Milojkovic, Leif Stenke, Eric Leip, Simon Purcell, Andrea Viqueira, Jorge E. Cortes
Publikováno v:
Blood. 140:3913-3915
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a52597bcef168a9dc616b44a342ebb4
https://doi.org/10.1182/blood-2022-163276
https://doi.org/10.1182/blood-2022-163276
Autor:
Philipp Grabel, Julian Thull, Martina Crysandt, Barbara M. Klinkhammer, Peter Boor, Tim H. Brummendorf, Dorit Merhof
Publikováno v:
2022 26th International Conference on Pattern Recognition (ICPR).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0de5719c9ddc29bb15c1846ffc47413c
https://doi.org/10.1109/icpr56361.2022.9956601
https://doi.org/10.1109/icpr56361.2022.9956601
Autor:
Tim H. Brummendorf, Patrick Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, Stefanie Meyer, Margaret C. Wey, Jamal Saeh, Richard F. Olsson, Arnon P. Kater
Publikováno v:
Blood. 140:3126-3127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::518b351af971809a530aca5886bdf098
https://doi.org/10.1182/blood-2022-167203
https://doi.org/10.1182/blood-2022-167203
Autor:
Philipp Grabel, Julian Thull, Martina Crysandt, Barbara M. Klinkhammer, Peter Boor, Tim H. Brummendorf, Dorit Merhof
Publikováno v:
2022 Eleventh International Conference on Image Processing Theory, Tools and Applications (IPTA).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3afb26821c493a098898bf049000d67
https://doi.org/10.1109/ipta54936.2022.9784119
https://doi.org/10.1109/ipta54936.2022.9784119
Autor:
Daniel Benten, Gunhild Keller, Alexander Quaas, Jorg Schrader, Artur Gontarewicz, Stefan Balabanov, Melanie Braig, Henning Wege, Jurgen Moll, Ansgar W. Lohse, Tim H. Brummendorf
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 9, Pp 934-944 (2009)
Patients with advanced stages of hepatocellular carcinoma (HCC) face a poor prognosis. Although encouraging clinical results have been obtained with multikinase inhibitor sorafenib, the development of improved therapeutic strategies for HCC remains a
Externí odkaz:
https://doaj.org/article/f44d5427273e43cfa4258d1f4c805c2b
Autor:
Tina Rohlfing, Thomas Streichert, Leendert H. J. Looijenga, Tim H. Brummendorf, Imke M. Veltman, Stefan Balabanov, Ad J. M. Gillis, Friedemann Honecker, Stephanie Glaesener, Carsten Bokemeyer, Benjamin Otto
Publikováno v:
Journal of Proteome Research. 7:3890-3899
Whereas clinical differences between testicular and extragonadal germ cell tumors (GCT), like reduced cisplatin sensitivity of extragonadal tumors, are well-established, little is known about underlying tumor biology. A combined approach using global
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc99021776d7ecdc9b014ddb65ea175
https://doi.org/10.1021/pr800173g
https://doi.org/10.1021/pr800173g
Publikováno v:
Current Stem Cell Research & Therapy. 2:31-38
The liver has a remarkable capability to restore its functional capacity following liver injury. According to the current paradigm, differentiated and usually quiescent hepatocytes are the primary cell type responsible for liver repair. As reserve co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb03ff27f89a30fdd67cbb59ba0289c
https://doi.org/10.2174/157488807779317062
https://doi.org/10.2174/157488807779317062
Autor:
Oliver M. Steinmetz, Barbara Eifrig, Florian Langer, Carsten Bokemeyer, Ali Amirkhosravi, Guy Marx, Tim H Brummendorf
Publikováno v:
American Journal of Hematology. 82:1122-1124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e4f25f42e7f4b6bf923b310d40acb7
https://doi.org/10.1002/ajh.20923
https://doi.org/10.1002/ajh.20923